News

Fosfomycin: as part of the consultation process new fosfomycin MIC data was submitted. The old and...

Read more

EUCAST still receives comments from colleagues in clinical microbiology that when organisms are...

Read more

The EUCAST general consultation on Corynebacterium diphtheriae and C. ulcerans is open for...

Read more

| Bacteria

Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially...

Read more

General warning against incomplete species and concentration range validation of commercially...

Read more

EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin....

Read more

EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin...

Read more

The Cefiderocol Rational Document has been revised. Link.

 

Read more

EUCAST Rapid AST directly from positive blood culture bottles, previously restricted to 4, 6 or 8...

Read more

Minor revision of the EUCAST Guidance on topical agents

Read more

How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff...

Read more

For many years EUCAST and other committees have struggled with the term “intrinsic resistance”....

Read more
previous 10 11 12 next

Contact

Looking for more information? Get in touch with an EUCAST representative today!

Contact form